| CL2397 |
|
127243-85-0 |
|
需詢價 |
C20 H20 Br N3 O2 S |
|
|
|
| CL2889 |
|
667463-62-9 |
(2'Z,3'E)-6-溴靛玉紅-3′-肟
BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO
3-5days
99+%
|
￥336.00 |
C16 H10BrN3O2 |
|
|
|
| CL2888A |
|
905854-03-7 |
(3S,4S)-替萬替尼
(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198
-
98+%
|
需詢價 |
C23H19N3O2 |
|
|
|
| CL1006C |
|
2109414-84-6 |
拉格魯西布二鹽酸鹽 | CHIR-99021二鹽酸鹽 |
Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride
-
98+%
|
需詢價 |
C22H18Cl2N8·2HCl |
|
|
|
| CL2733A |
|
2109704-99-4 |
甲磺酸貝舒地爾
Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate)
-
98+%
|
需詢價 |
C27H28N6O5S |
|
|
|
| CL2709 |
|
1422144-42-0 |
奈舒地爾甲磺酸鹽
Netarsudil dimesylate ( AR-13324 dimesylate)
-
98+%
|
需詢價 |
C30H35N3O9S2 |
|
|
|
| CL2506 |
|
40391-99-9 |
|
需詢價 |
C3H11NO7P2 |
|
|
|
| CL2425 |
|
425386-60-3 |
司馬西特
Semagacestat (LY450139)
In-stock
98+%
|
￥136.00 |
C19H27N3O4 |
|
|
|
| CLA1355 |
|
1447814-75-6 |
布隆妥珠單抗
Brontictuzumab (Anti-NOTCH1)
3-5days
95+%
|
￥3200.00 |
— |
|
|
|
| CLA1337 |
|
1345009-45-1 |
萬替妥單抗
Vantictumab (Anti-FZD)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1334 |
|
1359940-55-8 |
他瑞妥單抗
Tarextumab (Anti-NOTCH3)
3-5days
95+%
|
￥2200.00 |
— |
|
|
|
| CLA1299 |
|
1243262-17-0 |
登賽珠單抗
Demcizumab (Anti-DLL4)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CL2221 |
|
1226056-71-8 |
Thiazovivin
Thiazovivin
3-5days
98+%
|
￥700.00 |
C15H13N5OS |
|
|
|
| CL2213 |
|
686770-61-6 |
IWP-2
N -(6-Methyl-2-benzothiazolyl)-2-[(3?,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrim?idin-2-yl)thio]-acetamide
In-stock
98+%
|
￥520.00 |
C22H18N4O2S3 |
|
|
|
| CL1172 |
|
331752-47-7 |
(R)-(+)-反式-4-(1-氨基乙基)-N-(4-吡啶基)環(huán)己烷甲酰胺二鹽酸鹽單水合物/反-4-[(1R)-1-氨基乙基]-N-4-吡啶-環(huán)己甲酰胺鹽酸鹽一水合物
Y27632 HCl hydrate | (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate | Y-27632 Dihydrochloride Monohydrate
-
98+%
|
需詢價 |
C14H25Cl2N3O2 |
|
|
|
| CL1037 |
|
879085-55-9 |
維莫德吉
Vismodegib (GDC-0449)
In-stock
98+%
|
￥180.00 |
C19H14Cl2N2O3S |
|
|
|
| CL1006A |
|
1782235-14-6 |
CHIR-99021三鹽酸鹽 | 拉格魯西布三鹽酸鹽
Laduviglusib trihydrochloride | CHIR-99021 Trihydrochloride
-
98+%
|
需詢價 |
C22H18Cl2N8·3HCl |
|
|
|
| CL1006B |
|
1797989-42-4 |
CHIR-99021 鹽酸鹽 | 拉格魯西布鹽酸鹽
Laduviglusib monohydrochloride | CHIR-99021 Monohydrochloride | T99021 Monohydrochloride
-
98+%
|
需詢價 |
C22H18Cl2N8·HCl |
|
|
|
| CL1003A |
|
146986-50-7 |
Y-27632
Y-27632 (free base)
In-stock
Purity:>99.5% | EE:100%
|
￥556.00 |
C14H21N3O |
|
|
|
| CL1011 |
|
780757-88-2 |
(6S,9aS)-六氫-6-[(4-羥基苯基)甲基]-8-(1-萘基甲基)-4,7-二氧代-N-(苯甲基)-2H-吡嗪并[1,2-a]嘧啶-1(6H)-甲酰胺
ICG-001(ICG 001); (S,S)-ICG 001
In-stock
98+%
|
￥650.00 |
C33H32N4O4 |
|
|
|
